News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Drug Information Association 2014 50th Annual Meeting To Explore The Impact Of 3D Printing On Health Care


4/3/2014 2:12:37 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Experts to discuss how the revolutionary technology is used today and can reshape the future

WASHINGTON—Experts of 3D printing will discuss how the innovation could change drug discovery and health delivery, at the DIA 2014 50th Annual Meeting in San Diego. “Health Care’s Revolutionary Printing Press? 3D Printing – Blue Sky and Regulatory Path,” to be held on June 17 at 10:30 a.m. at the San Diego Convention Center, will identify the uses of 3D printing, the ways the technology can change medical product development and challenges in regulation.

“As 3D printing emerges on the health care landscape, it is not fully known how the bold technology may transform the industry as we know it today,” said Barbara L. Kunz, DIA global chief executive. “The DIA Annual Meeting will bring together subject matter experts behind 3D printing to explain how it will impact all arenas of drug development.”

3D printers use digital, three-dimensional design data to create medical products such as customized joint replacements. By building up a product layer by layer based on a digital model, a solid object of virtually any shape can be produced. The technology offers shorter production times and can save money by using fewer raw materials than do more traditional manufacturing methods. 3D printing capabilities are increasing—such as producing printed drugs, new tissue and bones—but regulatory guidelines do not yet exist.

Chaired by Nancy Bradish Myers, president and founder of Catalyst Healthcare Consulting, Inc., the session will feature a presentation about scientific policy on 3D printers by a representative of the Food and Drug Administration’s Office of Device Evaluation, and an industry perspective from Eric David, co-founder and chief strategy officer of Organovo. ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. DIA is an independent, nonprofit organization with its global center in Washington, D.C., regional offices covering North and South America (Horsham, Pa., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org or call DIA’s Global Center at +1.888.257.6457.

ABOUT DIA’s 2014 50th ANNUAL MEETING: Celebrate the Past – Invent the Future is the largest multidisciplinary event that brings together a community of life sciences professionals at all levels and across all disciplines involved in the discovery, development and life cycle management of medical products. The meeting aims to foster innovation that will lead to the development of safe and effective medical products and therapies for patients. www.diahome.org/dia2014

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES